| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059106A1 Isoindole-imide compounds, compositions, and uses thereof |
| 08/01/2002 | WO2002059105A1 Styrene derivatives and process for production thereof |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002059081A2 Urea derivatives as inhibitors of ccr-3 receptor |
| 08/01/2002 | WO2002058789A1 Ocular iontophoretic device and method of use |
| 08/01/2002 | WO2002058737A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002058728A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002058681A2 Use of rhein for preparing a medicine for treating a high level of il-1 |
| 08/01/2002 | WO2002058636A2 Novel cannabimimetic ligands |
| 08/01/2002 | WO2002042480A3 Modified vaccinia ankara virus variant |
| 08/01/2002 | WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 08/01/2002 | WO2002040461A3 Aminoalkoxybiphenyl carboxamides as histamine-3 receptor ligands and their therapeutic applications |
| 08/01/2002 | WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 08/01/2002 | WO2002014319A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002004019A3 Use of strains of the parapox ovis virus against organ fibrosis |
| 08/01/2002 | WO2001098279A3 Bis-arylsulfones |
| 08/01/2002 | WO2001096565A3 Binding agents: chimeric ligand/receptor proteins |
| 08/01/2002 | WO2001091799A3 Medicament for the treatment of immune reactions in the eye |
| 08/01/2002 | WO2001089538A3 Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| 08/01/2002 | WO2001089537A3 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 08/01/2002 | WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 08/01/2002 | WO2001085148A3 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001082953A3 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 08/01/2002 | WO2001078697A3 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 08/01/2002 | WO2001076606A3 Use of uric acid or precursors thereof as a treatment for cancer, aids and the like |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors |
| 08/01/2002 | WO2001065934A3 Applications of immune system tolerance to treatment of various diseases |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020103376 Dithiepino[6,5-b]pyridines, and related compositions and methods |
| 08/01/2002 | US20020103346 Reptile venom polypeptide for use in reduction of complement activity |
| 08/01/2002 | US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/01/2002 | US20020103335 Peptide derivatives |
| 08/01/2002 | US20020103235 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 08/01/2002 | US20020103212 Pharmaceutical compositions containing anti-fas antibody |
| 08/01/2002 | US20020103211 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 08/01/2002 | US20020103178 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 08/01/2002 | US20020103172 Vitamin d3 derivatives |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102656 Modulating the immune response |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102298 Temperature-sensitive liposomal formulation |
| 08/01/2002 | US20020102294 Aerosols comprising nanoparticle drugs |
| 08/01/2002 | US20020102279 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties |
| 08/01/2002 | US20020102251 Utilization of Wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
| 08/01/2002 | US20020102242 Compositions and methods for administering pneumococcal DNA |
| 08/01/2002 | CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435801A1 Styrene derivative and process for preparing the same |
| 08/01/2002 | CA2435672A1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | CA2435409A1 Novel cannabimimetic ligands |
| 08/01/2002 | CA2435124A1 Formulation of boronic acid compounds |
| 08/01/2002 | CA2435097A1 Peptides exibiting affinity for the viral protein gp120, and use of the se peptides |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2434052A1 Use of rhein for preparing a medicine for treating a high level of il-1 |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
| 08/01/2002 | CA2431177A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227098A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1226828A1 Medicinal compositions for inhibiting gvhd |
| 07/31/2002 | EP1226826A1 Remedies |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 07/31/2002 | EP1226252A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226251A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |